About Amylin Pharmaceuticals

Amylin Pharmaceuticals helps diabetics gain the upper hand in their battle with the disease. The company makes and markets injectable diabetes drugs Byetta and Symlin, which are approved as adjunct therapies to other diabetes treatments such as metformin and insulin. Byetta is also approved as a stand-alone diabetes therapy. Amylin gained FDA approval – more... 

Reviews

Overall

4.3
Based on 25 reviews
5 stars
4 stars
3 stars
2 stars
1 star
Work/Life Balance
Compensation/Benefits
Job Security/Advancement
Management
Culture
Claim this company page
Headquarters
9360 Towne Centre Dr.
San Diego CA, United States 92121
Revenue
$500M to $1B (USD)
Employees
1,001 to 5,000
Industry
Links
Amylin Pharmaceuticals website